IGMS - IGM Biosciences Total Debt to Capital
This price chart illustrates the dynamics of the separate_debt_total_eq metric, which currently stands at 0.00. IGM Biosciences, Inc. (IGMS) develops cutting-edge immunotherapies, leveraging partnerships with global industry behemoths to combat tumors. Business revenues are based on the integration of targeted biologics into the insurance system. Stable demand for medical innovations renders this sector a defensive asset, independent of external economic shocks.
%20-%20All%20Debt%20to%20Shareholders'%20Equity%20Ratio&width=1200&height=400&colorIndex=0&v=mvvwvvs9.gq-7b28iyo&start=20220704&end=20261031&filename=GURU_Markets_-_IGMS_-_IGM-Biosciences-Inc._-_All-Debt-to-Shareholders-Equity-Ratio "IGMS (IGM Biosciences) Total Debt to Capital history from 07/04/2022 to 08/24/2025 | 👁️GURU.Markets👁️")
Analytical breakdowns for IGM Biosciences, Inc.
- price and consensus price forecast:
- market capitalization statistics:
- book capitalization indicators:
- company total debt and liquidity indicators:
Debt to Equity IGM Biosciences, Inc.|IGMS - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital IGM Biosciences Inc.|IGMS - Company Aggregate Debts|Debt to Book Value IGM Biosciences|IGMS - Company Long-Term Loans and Borrowings|Company Short-Term Debts IGM Biosciences|Quick Liquidity igmbio.com
- earnings and valuation multiples information:
Basic company analysis:IGM Biosciences, Inc.
The financial stability of IGM Biosciences, Inc. (IGMS) is determined by the success of clinical trials and the support of strategic partners, which directly impacts the need for borrowed capital. This leverage metric—the ratio of total debt to equity—measures the proportion of credit funds within the balance sheet structure relative to equity, allowing for an assessment of the debt load and bankruptcy risks through an analysis of the chart's dynamics.
Competitor analysis for IGM Biosciences, Inc.
Debt to Equity argenx|BioNTech Inc. - Aggregate Debt to Equity|Total Debt to Capital ABVX|ADMA (ADMA Corp) - All Debt to Shareholders' Equity Ratio|Total Debt to Capital PTGX (Protagonist Therapeutics)|Total Debt to Capital immunovant.com IMVT|KNSA - Debt to Equity|All Debt to Shareholders' Equity Ratio GRFS (Grifols SA)|Adaptive Biotechnologies Corp (ADPT) - Debt to Equity|Total Debt to Equity Ratio Celldex Corp|AUPH (Aurinia Pharmaceuticals) - Total Debt to Capital|Total Debt to Capital biocryst.com|Total Debt to Equity Ratio VERA (Vera Therapeutics)|DNTH (Dianthus Therapeutics Inc) - All Debt to Shareholders' Equity Ratio|Total Debt to Capital PHVS (Pharvaris Corp)|Total Debt to Capital Coefficient AbCellera (ABCL)|TRML - Debt to Equity|precigen.com (PGEN) - Total Debt to Equity Ratio|Pharming Group (PHAR) - Debt to Equity|Total Debt to Equity Ratio Nektar Therapeutics Inc|Total Debt to Equity Ratio UPB|Total Debt to Capital Zenas Corp|Debt to Equity Immunome, Inc. (IMNM)|gossamerbio.com - Debt to Equity Ratio|Total Debt to Capital KALV (KalVista Pharmaceuticals, Inc.)|Septerna, Inc. (SEPN) - Debt to Capital|Pieris Pharmaceuticals Inc - Total Debt to Capital|Total Debt to Capital Coefficient Savara Pharma SVRA|RIGL: Total Debt to Capital|Debt to Capital Ratio anaptysbio.com ANAB|Debt to Equity Astria Therapeutics, Inc.|Total Debt to Equity Ratio enGene Holdings Inc (ENGN)|Total Debt to Equity Ratio RAPT (RAPT Therapeutics, Inc.)|JBIO (aerovatetx.com) - All Debt to Shareholders' Equity Ratio|Total Debt to Capital ACRS (Aclaris Therapeutics)|kyvernatx.com - Debt to Equity|Tiziana Life Sciences Ltd - Total Debt to Capital|Total Debt to Capital Coefficient Cabaletta Bio Inc. CABA|Ventyx Bio (VTYX) - Debt to Equity|Debt to Capital Theratechnologies, Inc (THTX)|Debt to Equity Avalo Therapeutics, Inc|eledon.com (ELDN) - Total Debt to Capital Coefficient|Total Debt to Capital AGEN|Total Debt to Equity Ratio Climb Bio Inc. CLYM|Total Debt to Capital ZURA (Zura Bio Limited)|Total Debt to Capital Coefficient aTyr Pharmaceuticals (ATYR)|Adagene Corp - Total Debt to Capital|Debt to Capital ImageneBio Inc|shattucklabs.com (STTK) - Debt to Equity|Debt to Equity Ratio EQ|CNTB (Connect Biopharma Holdings) - Total Debt to Capital|Total Debt to Equity Ratio Immunic Inc (IMUX)|Total Debt to Capital ATRA|IFRX - Debt to Capital|Debt to Equity X4 Pharmaceuticals, Inc. XFOR|Total Debt to Capital Coefficient Adicet Bio Inc. (ACET)|CELU: Total Debt to Equity Ratio|All Debt to Shareholders' Equity Ratio INMB (INmune Bio Corporation)|BRNS: Total Debt to Capital|KZR - Total Debt to Capital Coefficient|Debt to Equity SAB Biotherapeutics, Inc.|Debt to Equity Ratio AKTX (Akari Therapeutics PLC)|Total Debt to Capital ENLV|Total Debt to Equity Ratio q32bio.com QTTB|GeoVax Labs, Inc. - Total Debt to Equity Ratio|Total Debt to Capital Coefficient edesabiotech.com (EDSA)|iBio - Total Debt to Capital|Total Debt to Capital Coefficient Carisma Therapeutics CARM|XTLB: Total Debt to Capital|Debt to Capital Ratio Bolt Biotherapeutics, Inc. BOLT|Debt to Equity HCW Biologics, Inc.|Total Debt to Equity Ratio Aptevo (APVO)|Debt to Equity AIM ImmunoTech (AIM)|Total Debt to Capital Coefficient aditxt.com|Debt to Equity GRI Bio Corp GRI|XRTX (XORTX Corp) - Aggregate Debt to Equity|Vyome Holdings Inc - Total Debt to Capital|All Debt to Shareholders' Equity Ratio REVB (revbiosciences.com)|INDP: Total Debt to Capital|Scinai Immunotherapeutics Ltd (SCNI) - Total Debt to Capital|Debt to Equity CalciMedica Inc|AFMD: All Debt to Shareholders' Equity Ratio|Debt to Equity Allakos Inc. (ALLK)|Total Debt to Equity Ratio hookipapharma.com HOOK|Total Debt to Capital ITOS (iTeos Therapeutics, Inc.)|Total Debt to Capital Ocean Biomedical Inc OCEA|TCBP: Total Debt to Equity Ratio|All Debt to Shareholders' Equity Ratio THRD (Third Harmonic Bio Inc)